List of Microbiome Companies in Canada - 9

We apply proprietary computational tools to bacterial metabolomic and genomic data in order to identify, isolate, and assay novel drug-like small molecules in high-throughput to expedite the search for medicines that will better protect us from a wide spectrum of diseases.

Metabolica Health Inc. is a development stage biotechnology firm discovering and developing innovative treatments for diabetes and obesity.

MicroSintesis wants to change the way the world fights diseases. Our vision is a world having more creative and effective options to fight diseases and their consequences. To do so, we need to look elsewhere. There is a growing body of evidence that supports micro-organisms having the ability to communicate with one another. Quorum sensing is the source of microbiome's balance and helps avoid dysbiosis leading to diseases or infections. MicroSintesis wants to revolutionize human and animal welfare through harnessing microbiome's full potential. Amongst immediate challenges, we find antibiotic resistance. This has become an increasing threat to life. While the emergence of new resistant pathogens is accelerating, the ones already there are strengthening. Medical professionalss want to reduce the use of antibiotics, but evidently will not settle for less effectiveness. MicroSintesis is not just another probiotic company. We go a step ahead, strive for discovery and strongly believe that providing health practitioners with a response to antimicrobial resistance should find its way through science. Our solutions leverage years of worldwide scientific discoveries. We believe that our unique patented metabolite is at the heart of microbiome's communication system. MicroSintesis pioneers the creation of a new generation of science-based microbiome and health technologies. We are committed to lead microbiome's research, discover proven & effective alternative to antibiotics, impact long standing health challenges, improve human and animal welfare and promote access to new and effective health solutions.

Moss is a disrupter in the consumer healthcare space offering personalized health and gut health solutions guided by genomic data, microbiome data, and clinically validated assessments. Founded in 2018, Moss is a technology and healthcare integrator for personalized health and offers a comprehensive line of probiotics and nutritional supplements.

Noa Therapeutics is a preclinical biotech company pioneering the development of multimodal therapies. Singular, non-steroidal, small molecules with tunable therapeutic drivers are offered to address complex immune diseases, enabling patients to achieve better outcomes.

Welcome to Ostia Sciences, a premier microbiome solutions company that specializes in discovering novel bacterial metabolites with antibacterial, antibiofilm, and immunomodulation activities. Our goal is to isolate beneficial microbes from the human oral microbiome, human breast milk, and fermented food, which are known to be rich sources of ribosomally synthesized and post-translationally modified peptides (RiPPs) and natural products with a range of biological activities.

Pan-Biome Pharmaceuticals, Inc, is a Vancouver-based preclinical biopharmaceutical company spun out two years ago with a focus on developing safe and highly effective drugs to promote healthy aging and healthspan. We recently developed a new generation of natural product-based small molecule compounds that exhibit a variety of beneficial biological activities with the potential to modulate important pathways that, when altered, can lead to the development of inflammatory, immune and degenerative diseases.

Starpax Biopharma Inc. has developed a novel Precision 3D Guidance Therapy of Magnetodrones™ in tumors. Magnetodrones™ are unique medication-bearing bacteria, developed by Starpax™, that are sensitive to magnetic fields. They deliver the medication into the mass of the tumour, without allowing the medication to circulate in the bloodstream. At the same time, the Magnetodrones™ saturate hypoxic areas where cancerous cells are difficult to reach with other treatments. Magnetodrones are injected directly into the tumour and are guided by the PolarTrak device, in which the patient is positioned. The PolarTrak™ prevents the Magnetodrones™ from leaving the tumour and guides them in 3D with special magnetic fields. Starpax Biopharma inc. a développé une thérapie inédite de guidage de précision 3D de Magnétodrones™ dans les tumeurs.. Les Magnétodrones™ sont des bactéries uniques développées par Starpax, sensibles aux champs magnétiques, sur lesquelles sont attachés les médicaments à leur surface. Les Magnétodrones™ distribuent des médicaments dans la masse des tumeurs sans circuler dans le réseau sanguin, tout en saturant les zones hypoxiques où les cellules cancéreuses sont difficiles à atteindre par le biais d'autres traitements. Les Magnétodrones™ sont injectés directement dans la tumeur et guidés par l'appareil PolarTrak™, où le patient est installé. Le PolarTrak™ empêche les Magnétodrones™ de sortir de la tumeur et les guide en 3D grâce à ses champs magnétiques spéciaux.